pyrazolanthrone has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P; Li, C; Li, D; Liang, J; Ruan, J; Wang, J; Xue, R; Zhang, S; Zhang, X | 1 |
| Chen, L; Ren, W; Shen, Z; Wu, J; Yang, X | 1 |
2 other study(ies) available for pyrazolanthrone and Psoriasis
| Article | Year |
|---|---|
IL-22 Down-Regulates Cx43 Expression and Decreases Gap Junctional Intercellular Communication by Activating the JNK Pathway in Psoriasis.
Topics: Adult; Anthracenes; Cell Communication; Cell Line; Connexin 43; Down-Regulation; Female; Gap Junctions; Humans; Interleukin-22; Interleukins; JNK Mitogen-Activated Protein Kinases; Keratinocytes; Male; MAP Kinase Signaling System; Middle Aged; Psoriasis; Skin | 2019 |
c-Jun N-terminal kinase (JNK)-phospho-c-JUN (ser63/73) pathway is essential for FOXP3 nuclear translocation in psoriasis.
Topics: Active Transport, Cell Nucleus; Adolescent; Adult; Aged; Anthracenes; Cell Nucleus; Child; Cytoplasm; Enzyme Inhibitors; Female; Forkhead Transcription Factors; Humans; Interleukin-17; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Middle Aged; Phosphorylation; Psoriasis; T-Lymphocytes, Regulatory; Ultraviolet Rays; Young Adult | 2013 |